Phenylalanine derivatives as alpha 4 integrin inhibitors

Details Phenylalanine derivatives as alpha 4 integrin inhibitors Phenylalanine derivatives as alpha 4 integrin inhibitors

2007-11-06

2007-11-06

Tucker, Zachary C (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

N-c doai

C560S133000

Reexamination Certificate

active

10735499

ABSTRACT:
Disclosed are a series of phenylalanine derivatives, to compositions containing them, to processes for their preparation, and to their use in medicine.

REFERENCES:
patent: 99/06435 (1999-02-01), None
patent: 99/43642 (1999-09-01), None
Vippagunta et al, “Crystalline Solids” Advanced Drug Delivery Reviews, vol. 48, pp. 3-26 (2001).
Gavezzotti, “Are Crystal Structures Predictable?” Accounts of Chemical Research, vol. 27, pp. 309-314 (1994).
Miller et al, “Discovery of Orally Active Nonpeptide Vitronectin Receptor Antagonists Based on a 2-Benzazepine Gly-Asp Mimetic” Journal of Medicinal Chemstry, vol. 43, pp. 22-26 (2000).
Badger et al, “Disease-Modifying Activity of SB 273005, an Orally Active Nonpeptide αvβ3 (Vitronectin Receptor) Antagonist, in Rat Adjuvant-Induced Arthritis” Arthritis & Rheumatism, vol. 44(1), pp. 128-137 (2001).
Lark et al, “Antagonism of the Osteoclast Vitronectin Receptor with an Orally Active Nonpeptide Inhibitor Prevents Cancellous Bone Loss in the Ovarectomized Rat” Journal of Bone and Mineral Research, vol. 16(2), pp. 319-327 (2001).
Lee et al, “Solid-Phase Synthesis of 3,4,5-Substituted 1,5-Benzodiazepin-2-ones” Journal of Organic Chemistry, vol. 64, pp. 3060-3065 (1999).
Abraham, W.M., et al.,J. Clin. Invest., 93 (1994), p. 776.
Berlin, C., et al.,Cell, 74 (1993), p. 185.
Binns, R.M., et al.,J. Immunol., 157, (1996), p. 4094.
Briskin, M. J., et al.,J. Immunol., 156 (1996), p. 719.
Cardarelli, P.M., et al.,J. Biol. Chem., 296, (1994), p. 18668.
Humphries, M.J., et al.,Ciba Foundation Symposium, 189, (1995), p. 177.
Issekutz, T.B.J.,Immunol, (1992), p. 3394.
Li, Z., et al.,Am. J. Physiol., 263, (1992), p. L723.
Marlin, S.D., et al.,Exp. Med., 164, (1986), p. 855.
Osborne, L.,Cell, 62, (1990), p. 3.
Podolsky, D.K., et al.,J. Clin. Invest., 92, (1993), p. 373.
Shroff, H.N.,Bioorganic. Mwed., Chem. Lett., 6 (1996), p. 2495.
Sonnenberg, A.,Current Topics in Microbiology and Immunology, 18, (1993), p. 7.
Springer, T.A., et al.,Cell, 76 (1994), p. 301.
Springer, T.A., et al.,Nature, 346, (1990), p. 425.
Vanderslice, P.,J. Immunol, 158, (1997), p. 1710.
Yang, X-D., et al.,PNAS., 91, (1994), p. 12604.

Affiliated with

Also associated with

Rating

Phenylalanine derivatives as alpha 4 integrin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phenylalanine derivatives as alpha 4 integrin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenylalanine derivatives as alpha 4 integrin inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3889449